Clinical compliance with an oral uracil/tegafur (UFT) plus leucovorin (LV) regimen as adjuvant chemotherapy in Japanese colorectal cancer patients

International Journal of Clinical Oncology

Volumn 14, Issue 5, 2009, Pages 402-407

  Meguro, Makoto ^a   Furuhata, Tomohisa ^a   Okita, Kenji ^a   Nishidate, Toshihiko ^a   Ishiyama, Gentaro ^a   Iwayama, Yuji ^a   Kimura, Yasutoshi ^a   Mizuguchi, Toru ^a   Hirata, Koichi ^a  

^a SAPPORO MEDICAL UNIVERSITY SCHOOL OF MEDICINE   (Japan)

Author keywords

Adjuvant; Compliance; Leucovorin; Toxicity; UFT

Indexed keywords

FOLINIC ACID; UFT;

ADJUVANT CHEMOTHERAPY; ADJUVANT THERAPY; ADULT; AGED; ANEMIA; ANOREXIA; ARTICLE; BLOOD TOXICITY; CANCER SURGERY; CLINICAL ARTICLE; COLORECTAL CANCER; COLORECTAL SURGERY; CONTROLLED STUDY; DIARRHEA; DISEASE SEVERITY; DRUG CAPSULE; DRUG WITHDRAWAL; FATIGUE; FEMALE; HUMAN; JAPANESE; MALE; MUCOSA INFLAMMATION; MULTIPLE CYCLE TREATMENT; NAUSEA; NEUTROPENIA; OUTPATIENT CARE; PATIENT COMPLIANCE; PIGMENTATION; POSTOPERATIVE CARE; PRIORITY JOURNAL; SIDE EFFECT; STOMATITIS; TABLET FORMULATION; THROMBOCYTOPENIA; TREATMENT OUTCOME; VOMITING;

ADMINISTRATION, ORAL; ADULT; AGED; AGED, 80 AND OVER; AMBULATORY CARE; ANTIMETABOLITES, ANTINEOPLASTIC; ANTINEOPLASTIC COMBINED CHEMOTHERAPY PROTOCOLS; ASIAN CONTINENTAL ANCESTRY GROUP; CAPSULES; CHEMOTHERAPY, ADJUVANT; COLECTOMY; COLORECTAL NEOPLASMS; DRUG ADMINISTRATION SCHEDULE; FEMALE; HUMANS; JAPAN; LEUCOVORIN; MALE; MEDICATION ADHERENCE; MIDDLE AGED; TABLETS; TEGAFUR; TREATMENT OUTCOME;

EID: 70350496034     PISSN: 13419625     EISSN: None     Source Type: Journal    
DOI: 10.1007/s10147-009-0888-1     Document Type: Article

References (12)

1. Y. Komatsu 2007 Adjuvant chemotherapy for colorectal cancer in Japan-current state and problem areas Gan To Kagaku Ryoho 34 799 807 17496461
2. B.C. Lembersky H.S. Wieand N.J. Petrelli, et al. 2006 Oral uracil and tegafur plus leucovorin compared with intravenous fluorouracil and leucovorin in stage II and III carcinoma of the colon: results from National Surgical Adjuvant Breast and Bowel Project Protocol C-06 J Clin Oncol 24 2059 2064 10.1200/JCO.2005.04.7498 1:CAS:528:DC%2BD28Xlt1amurk%3D 16648506 (Pubitemid 46622115)
3. M.M. Borner P. Schoffski R. de Wit, et al. 2002 Patient preference and pharmacokinetics of oral modulated UFT versus intravenous fluorouracil and leucovorin: a randomised crossover trial in advanced colorectal cancer Eur J Cancer 38 349 358 10.1016/S0959-8049(01)00371-9 1:CAS:528:DC%2BD38XovFShsQ%3D%3D 11818199 (Pubitemid 34121962)
4. D.J. Kim T.I. Kim J.H. Suh, et al. 2003 Oral tegafur-uracil plus folinic acid versus intravenous 5-fluorouracil plus folinic acid as adjuvant chemotherapy of colon cancer Yonsei Med J 44 665 675 1:CAS:528: DC%2BD3sXnvVKltL8%3D 12950123
5. W.L. Ward E.A. Hahn F. Mo, et al. 1999 Reliability and validity of the Functional Assessment of Cancer Therapy-Colorectal (FACT-C) quality of life instrument Qual Life Res 8 181 195 10.1023/A:1008821826499 1:STN:280: DyaK1MvgtFeksg%3D%3D 10472150 (Pubitemid 29367288)
6. K. Ota T. Taguchi K. Kimura, et al. 1988 Report on nationwide pooled data and cohort investigation in UFT phase II study Cancer Chemother Pharmacol 22 333 338 10.1007/BF00254241 1:STN:280:DyaL1M%2FgtlCjtA%3D%3D 3139315
7. J.Y. Douillard P.M. Hoff J.R. Skillings, et al. 2002 Multicenter phase III study of uracil/tegafur and oral leucovorin versus fluorouracil and leucovorin in patients with previously untreated metastatic colorectal cancer J Clin Oncol 20 3605 3616 10.1200/JCO.2002.04.123 1:CAS:528:DC%2BD38XntVynsro%3D 12202661 (Pubitemid 34983220)
8. J. Carmichael T. Popiela D. Radstone, et al. 2002 Randomized comparative study of tegafur/uracil and oral leucovorin versus parenteral fluorouracil and leucovorin in patients with previously untreated metastatic colorectal cancer J Clin Oncol 20 3617 3627 10.1200/JCO.2002.10.129 1:CAS:528:DC%2BD38XntVynsrs%3D 12202662 (Pubitemid 34983221)
9. J.A. Kopec G. Yothers P.A. Ganz, et al. 2007 Quality of life in operable colon cancer patients receiving oral compared with intravenous chemotherapy: results from National Surgical Adjuvant Breast and Bowel Project Trial C-06 J Clin Oncol 25 424 430 10.1200/JCO.2005.05.2597 17264338 (Pubitemid 350002991)
10. J. Maroun C. Asche F. Romeyer, et al. 2003 A cost comparison of oral tegafur plus uracil/folinic acid and parenteral fluorouracil for colorectal cancer in Canada Pharmacoeconomics 21 1039 1051 10.2165/00019053-200321140-00004 1:CAS:528:DC%2BD3sXptV2ks7o%3D 13129416 (Pubitemid 37255457)
11. Y. Ogata S. Torigoe K. Matono, et al. 2005 Prognostic factors after potentially curative resection in stage II or III colon cancer Kurume Med J 52 67 71 10.2739/kurumemedj.52.67 16422171 (Pubitemid 43251063)
12. H.S. Hochster W. Luo E.C. Popa, et al. 2007 Phase II study of uracil-tegafur with leucovorin in elderly (≥75 years old) patients with colorectal cancer: ECOG 1299 J Clin Oncol 25 5397 5402 10.1200/JCO.2006.10.4521 1:CAS:528:DC%2BD1cXnvVCjug%3D%3D 18048821 (Pubitemid 350232215)